Medications for Anaplastic Large Cell Lymphoma
These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Anaplastic Large Cell Lymphoma.
Found 2 Approved Drugs for Anaplastic Large Cell Lymphoma
Adcetris
Generic Name
Brentuximab Vedotin
Adcetris
Generic Name
Brentuximab Vedotin
Form: Injection
Method of administration: Intravenous
FDA approval date: August 25, 2011
Classification: CD30-directed Immunoconjugate
ADCETRIS is a CD30-directed antibody and microtubule inhibitor conjugate indicated for treatment of: Adult patients with previously untreated Stage III or IV classical Hodgkin lymphoma (cHL), in combination with doxorubicin, vinblastine, and dacarbazine.
Xalkori
Generic Name
Crizotinib
Xalkori
Generic Name
Crizotinib
Form: Capsule
Method of administration: Oral
FDA approval date: August 26, 2011
Classification: Kinase Inhibitor
XALKORI is a kinase inhibitor indicated for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) whose tumors are anaplastic lymphoma kinase (ALK) or ROS1-positive as detected by an FDA-approved test.
Showing 1-2 of 2
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances